← Back to Clinical Trials
Recruiting NCT07203742

NCT07203742 The Effect of Mandala on Anxiety and Fear Levels in Children With Leukemia Before Intrathecal Chemotherapy Treatment

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07203742
Status Recruiting
Phase
Sponsor Ege University
Condition Acute Lymphoblastic Leukemia
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2025-09-29
Primary Completion 2026-08

Trial Parameters

Condition Acute Lymphoblastic Leukemia
Sponsor Ege University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 60
Sex ALL
Min Age 4 Years
Max Age 12 Years
Start Date 2025-09-29
Completion 2026-08
Interventions
mandala painting

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study aims to examine the effect of mandala coloring activity, administered before intrathecal chemotherapy treatment in children with leukemia, on pre-procedure anxiety and fear in children. The main question this study aims to answer is: Does mandala coloring administered before intrathecal chemotherapy treatment reduce pre-procedure anxiety and fear in children with leukemia? Descriptive demographic data will be collected from the children who will be given mandalas. Data will be collected using an Anxiety Scale and a Fear Scale.

Eligibility Criteria

Inclusion Criteria: * The patient must be between 4 and 12 years of age. * The patient must be hospitalized and followed up at the Pediatric Hematology Clinic. * The patient must only be receiving leukemia treatment. * The patient must not have any other chronic diseases. * The patient must not have any systemic infections. * The patient has received at least two courses of intrathecal chemotherapy treatment * The patient does not have a diagnosis of psychological/mental symptoms as a side effect of chemotherapy treatment * Intrathecal treatment will be administered to the patient in accordance with the chemotherapy protocol * The patient and the caregiver parent are volunteers * The caregiver parent speaks Turkish and is open to communication. Exclusion Criteria: * Cases that do not meet the inclusion criteria will be excluded from the study.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology